These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16310890)

  • 1. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
    Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
    J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak.
    Hautemanière A; Hunter PR; Diguio N; Albuisson E; Hartemann P
    Am J Infect Control; 2009 Nov; 37(9):746-52. PubMed ID: 19556034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycopeptide-resistant Enterococcus raffinosus in a haematology unit: an unusual cause of a nosocomial outbreak.
    Samuel J; Coutinho H; Galloway A; Rennison C; Kaufmann ME; Woodford N
    J Hosp Infect; 2008 Nov; 70(3):294-6. PubMed ID: 18783849
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci: mechanisms and clinical observations.
    Gold HS
    Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant enterococci: implications for infection control.
    Molyneux R; Chadwick C
    Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycopeptide-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones].
    Delamare C; Lameloise V; Lozniewski A; Perrin M; Baudin C; Sellies J; Dumay M; Bemer M;
    Pathol Biol (Paris); 2008; 56(7-8):454-60. PubMed ID: 18835105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
    Leclercq R
    Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin resistant Enterococci in a tertiary care hospital in Mumbai.
    De A; Bindlish A; Kumar S; Mathur M
    Indian J Med Microbiol; 2009; 27(4):375-6. PubMed ID: 19736416
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004-2009.
    Henard S; Gendrin V; Simon L; Jouzeau N; Vernier N; Thiolet JM; Coignard B; Rabaud C
    Int J Hyg Environ Health; 2011 Jun; 214(3):265-70. PubMed ID: 21330205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
    Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?
    Humphreys H
    J Hosp Infect; 2006 Feb; 62(2):133-5. PubMed ID: 16337032
    [No Abstract]   [Full Text] [Related]  

  • 13. VRE--what every health care provider needs to know.
    Mikos-Schild S
    Todays Surg Nurse; 1998; 20(3):13-6; quiz 40-1. PubMed ID: 10026632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked.
    McGowan JE
    J Hosp Infect; 2004 Aug; 57(4):281-4. PubMed ID: 15320355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare-associated versus community-acquired infections: a new challenge for science and society.
    Gastmeier P
    Int J Med Microbiol; 2010 Aug; 300(6):342-5. PubMed ID: 20452277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
    Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Chmura A; Rowiński W
    Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing vancomycin-resistant enterococci. A winning team approach.
    Robinson K; Duff Z; Mercer J; Cran M; Gill-Morton P; Main S
    Can Nurse; 1997 Nov; 93(10):36-9. PubMed ID: 9444145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.